In passionate appeal, Enamine CEO asks for pharma industry's help to isolate Russia and slow invasion

Max Gelman

Senior Editor

As Russia’s invasion of Ukraine continues, the CEO of a Ukrainian company responsible for supplying much of the pharma world with chemical building blocks is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

In passionate appeal, Enamine CEO asks for pharma industry's help to isolate Russia and slow invasion

Max Gelman

Senior Editor

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Will CRISPR matter?

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

In pas­sion­ate ap­peal, Enam­ine CEO asks for phar­ma in­dus­try's help to iso­late Rus­sia and slow in­va­sion

Senior Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

In passionate appeal, Enamine CEO asks for pharma industry's help to isolate Russia and slow invasion